Morepen Laboratories and the Corinth Group Connection
Morepen Laboratories Ltd is an Indian pharmaceutical company whose filings reference share allotments involving Corinth Group entities. This page examines the documented connection.
The Morepen Connection
Morepen Laboratories Ltd (BSE: 500288), listed on the Bombay Stock Exchange, is referenced in Companies House filings for UK entities within the Three Tuns / Corinth network. The filings relate to share allotments involving Corinth-associated entities [Companies House filings, Morepen Laboratories BSE filings].
Significance
The Morepen deal is notable as one of the few documented instances where Corinth Group entities appear in transactions involving a publicly listed company. Whether this deal was completed as represented to complainants, and what its actual terms and outcomes were, are open questions that require verification through Morepen Laboratories' annual reports [Public filings].
Open Questions
Key unanswered questions include: (1) Were the share allotments completed as filed? (2) What consideration was paid? (3) Were any Corinth Group clients' funds involved? (4) Does Pinfold Overseas Limited (7.03% Morepen shareholder) represent a related-party transaction? These questions are documented in the investigation's gaps register for future research [Investigation gaps register].
Key Facts
- Morepen Laboratories Ltd — BSE: 500288, Indian pharmaceutical company
- Share allotments referencing Corinth entities in UK filings
- Pinfold Overseas Limited — 7.03% Morepen shareholder, possible Corinth link
- One of few documented transactions involving a publicly listed company
- Verification needed through Morepen annual reports 2021–2023
Complaint Reports
People Involved
Related Entities
Related Investigations
Have You Been Affected?
If you have information about any of the people or entities described on this site, your account could help ongoing investigations and other affected parties.
Contact Us Confidentially